Abstract
This study estimates diagnostic performance of late-night salivary cortisol (LNSC) as measured by automated electrochemiluminescence immunoassay (ECLIA), evaluates the clinical implication of two consecutive LNSC measurements, and compares its accuracy with enzyme-linked immunosorbent assay (ELISA) and serum cortisol after low-dose dexamethasone suppression test (DST) in obese and overweight patients referred for suspected Cushing’s syndrome (CS). One hundred twenty three consecutive obese and overweight referred patients and 98 healthy volunteers provided two saliva samples collected at 23:00 using a Salivette (Sarstedt, Germany), assayed by ECLIA (Cobas e601) and ELISA. The patients underwent DST and were further evaluated until CS was pathologically confirmed (n = 45) or excluded. Diagnostic performance of LNSC was evaluated by receiver operating characteristic (ROC) analysis. The total areas under the curve (AUC) were calculated to compare the different tests. We found that a cut-off value of 9.4 nmol/l can differentiate CS among obese and overweight patients with sensitivity of 84.4 % (95% CI 71.2–92.2), specificity of 92.3 % (95% CI 84.2–96.4), and diagnostic odds ratio of 65.1 (95% CI 20.4–207.6). No difference was found between AUCs from the first, second, and the mean from the two LNSC measurements (ECLIA), LNSC (ELISA), or DST. The single LNSC (ECLIA) and DST improved the sensitivity and specificity for concordant results up to 100 and 97.4 %, respectively. In conclusion, due to its automation and its comparable diagnostic performance, ECLIA is preferable as a first-line LNSC screening test for CS. The initial use of single LNSC followed by DST provides better diagnostic performance for concordant results.
Similar content being viewed by others
References:
C. Steffensen, A.M. Bak, K.Z. Rubeck, J.O.L. Jorgensen, Epidemiology of Cushing’s syndrome. Neuroendocrinology 92(1), 1–5 (2010)
B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88, 5808–5813 (2003)
G. Leibowitz, A. Tsur, S.D. Chayen, M. Salameh, I. Raz, E. Cerasi, D.J. Gross, Pre-clinical Cushing’s syndrome an unexpected frequent cause of poor glycemic control in obese diabetic patients. Clin. Endocrinol. (Oxf). 44, 712–722 (1996)
M. Omura, K. Yamaguchi, Y. Kakuta, T. Nishikawa, Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens. Res. 27, 193–202 (2004)
I. Chiodini, M.L. Mascia, S. Muscarella, C. Battista, S. Minisola, M. Arosio, S.A. Santini, G. Guglielmi, V. Garnevale, A. Scillitani, Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann. Intern. Med. 147, 541–548 (2007)
I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case–control study in hospitalized patients. Eur. J. Endocrinol. 153, 837–844 (2005)
C. Davenport, A. Liew, B. Doherty, H.H.N. Win, H. Misran, S. Hanna, D. Kealy, F. Al-Nooh, A. Agha, C.J. Thompson, M. Lee, D. Smith, The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 40, 80–83 (2011)
D.A. Vassiliadi, G. Ntali, T. Stratigou, M. Adali, S. Tsagarakis, Abberant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas. Endocrine 40, 437–444 (2011)
L.K. Nieman, B.M.K. Biller, J.W. Finding, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin Endocrinol Metab. 93, 1526–1540 (2008)
P. Putignano, P. Toja, A. Dubini, P.F. Giraldi, S.M. Corsello, F. Cavaqnini, Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J. Clin. Endocrinol Metab 88, 4153–4157 (2003)
J.P. Kahn, D.R. Rubinov, C.L. Davis, M. Kling, R.M. Post, Salivary cortisol: a practical method for evaluation of adrenal function. Biol. Psychiatry 23, 335–349 (1988)
J. Guechot, J. Fiet, P. Passa, J.M. Villette, B. Gourmel, F. Tabuteau, G. Cathelineau, Dreux C Physiological and pathological variations in saliva cortisol. Horm. Res. 16, 357–364 (1982)
P.J. Evans, J.R. Peters, J. Dyas, R.F. Walker, D. Riad-Fahmy, R. Hall, Salivary cortisol levels in true and apparent hypercortisolism. Clin Endocrinol. (Oxf). 20, 709–715 (1984)
H. Raff, J.L. Raff, J.W. Finding, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)
D.A. Papanicolaou, N. Mullen, I. Kyrou, L.K. Nieman, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 87, 4515–4521 (2002)
A. Viardot, P. Huber, J.J. Puder, H. Zulewski, U. Keller, B. Muller, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730–5736 (2005)
S. Kidambi, H. Raff, J.W. Finding, Limitation of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157, 725–731 (2007)
T. Deutschbein, N. Unger, J. Hinrichs, M.K. Walz, K. Mann, S. Petersen, Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenoma. Eur. J. Endocrinol. 161, 747–753 (2009)
S. Sakihara, K. Kageyama, Y. Oki, M. Doi, Y. Iwasaki, S. Takayasu, T. Moriyama, K. Terui, T. Nigawara, Y. Hirata, K. Hashimoto, T. Suda, Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr. J. 57, 331–337 (2010)
H. Raff, S.L. Ettema, D.C. Eastwood, B.T. Woodson, Salivary cortisol in obstructive sleep apnea: the effect of CPAP. Endocrine 40, 137–139 (2011)
K.I. Alexandraki, A.B. Grossman, Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92(1), 35–43 (2010)
S.K. Baid, N. Sinaii, M. Wade, D. Rubino, L.K. Nieman, Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92, 3102–3107 (2007)
G. Beko, I. Varga, E. Glaz, M. Sereg, K. Feldman, M. Toth, K. Racz, A. Patocs, Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin. Chim. Acta 411, 364–367 (2010)
S.M. Baid, D. Rubino, N. Sinaii, S. Ramsey, A. Frank, L.K. Nieman, Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J. Clin. Endocrinol. Metab. 94, 3857–3864 (2009)
M. Boscaro, G. Arnaldi, Approach to the patient with possible Cushing’s syndrome. J. Clin. Endocrinol. Metab. 94, 3121–3131 (2009)
M. Nunes, S. Vattaut, J. Corcuff, A. Rault, H. Loiseau, B. Gatta, N. Valli, L. Letenneur, A. Tabarin, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456–462 (2009)
K.H. Zou, J. O’Maley, L. Mauri, Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115, 654–657 (2007)
O Ajetunmobi, Making sense of critical appraisal (Hodder Arnold part of Hachette, London, 2002). pp. 69–84
J.A. Hanley, B.J. McNeil, The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29–36 (1982)
J.A. Hanley, B.J. McNeil, A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148, 839–843 (1983)
K. Jeyaraman, A.C. Amini, G. Nandita, S.N. Dwivedi, Late-night salivary cortisol in normal subjects and in patients with Cushing’s syndrome. Postgrad Med J. 86, 399–404 (2010)
C. Carrozza, S.M. Corsello, R.M. Paragliola, F.I.S. Palumbo, P. Locantore, A. Sferrazza, A. Pontecorvi, C. Zuppi, Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann. Clin. Biochem. 47, 228–232 (2010)
M. Yaneva, G. Kirilov, S. Zacharieva, Midnight salivary cortisol, measured by highly sensitive electrochemiluminescene immunoassay, for the diagnosis of Cushing’s syndrome. Cent. Eur. J. Med. 4, 59–64 (2009)
M. Sereg, J. Toke, A. Patocs, I. Varga, P. Igaz, N. Szucs, J Horanyi, P. Pusztai, S. Czirjak, E. Glaz, K. Racz, M. Toth, Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing’s syndrome. Steroids. 76, 38–42 (2011)
M. Vogeser, J. Durner, E. Seliger, C. Auernhammer, Measurement of late-night salivary cortisol with an automated immunoassay system. Clin. Chem. Lab. Med. 44, 1441–1445 (2006)
CA Carrasco, M Garcia, M Goycoolea, J Cerda, J Berherat, O. Padilla, D. Meza, N. Wohllk, T Quiroga, Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system. Endocrine. (2012). doi:10.1007/s12020-012-9597-z
Acknowledgments
This work was supported by the Presidential Grant no. MК-6978.201
Disclosure
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Belaya, Z.E., Iljin, A.V., Melnichenko, G.A. et al. Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 41, 494–500 (2012). https://doi.org/10.1007/s12020-012-9658-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9658-3